A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer
暂无分享,去创建一个
Qiang-hua Zhou | Min Xu | F. Fang | Yuqi Su | Erdong Shen | J. Weng | Fang Wen | Chuanyi Zhou | Jianbing Hu | P. Luo | Gou Zhan | Shi-nian Da | Songlian Liu | Dahe Zhan